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P fimbria, a mannose-resistant adhesin of uropathogenic
Escherichia coli (UPEC), has been shown to be associated with
acute pyelonephritis. The pap gene cluster encodes the
proteins required for P-fimbrial biogenesis, including papG,
which encodes the tip adhesin. The three most studied PapG
molecular variants, which are shown to bind distinct
isoreceptors, are PapGI, -II, and -III. PapGII preferentially binds
globoside, or GbO4, a glycolipid isoreceptor of the human
kidney. Studies using different animal models of ascending
urinary tract infection (UTI) have demonstrated a variable
role for P fimbriae, and specifically PapGII-mediated
adherence, in renal colonization. The disparities in the results
obtained from those studies are likely to be attributed to the
differences in animal models and UPEC strains utilized. One
explanation that is discussed in detail is the contribution of
multiple fimbriae of UPEC that potentially mediate adherence
to the mammalian kidney. Overall, P fimbriae appear to play
some role in mediating adherence to uroepithelial cells in
vivo and establishing an inflammatory response during renal
colonization, thus contributing to kidney damage during
acute pyelonephritis. To verify that P fimbriae contribute to
the pathogenesis of UPEC during ascending UTI (and in
particular acute pyelonephritis), future studies should be
conducted to satisfy fully all three tenets of the molecular
Koch’s postulates, including complementation of a mutated
allele.
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While the urinary tract of a healthy adult is generally sterile,
it is also the most common site of bacterial infection. In
general, urinary tract infections (UTIs) develop in an
ascending manner beginning with peri-urethral colonization,
followed by ascension of the urethra into the bladder causing
cystitis, and in some cases if left untreated, ascension of the
ureters into the kidneys establishing acute pyelonephritis.
Acute pyelonephritis is considered the most serious UTI as it
is known to typically cause scarring of the kidney, which may
in turn lead to irreversible kidney damage, kidney failure,
and/or sepsis. In more than 80% of all uncomplicated acute
pyelonephritis cases, the etiologic agent is uropathogenic
Escherichia coli (UPEC).1
An important stage in the successful colonization of the
urinary tract and pathogenesis of UTI is the ability of UPEC
to adhere to host uroepithelia. In 1976, Ede´n et al.2
demonstrated that E. coli isolated from the urine of patients
with acute symptomatic pyelonephritis adhered in greater
numbers to exfoliated uroepithelial cells than E. coli isolated
from the urine of patients with asymptomatic bacteriuria.
Two years later, the ability of UPEC to attach to human
uroepithelial cells was attributed to the presence of fimbriae
(or pili), which appear as hair-like appendages that protrude
from the surface of bacteria.3 These fimbriae were determined
to be distinct from the common fimbriae (otherwise known
as type 1 fimbriae) in that they mediated adherence to
uroepithelial cells in the presence of mannose, a known
inhibitor of type 1-mediated adherence.3
The most extensively studied adhesin, and also the first
virulence-associated factor identified for UPEC is P fimbria.
P fimbriae, encoded by the pap (pyelonephritis-associated
pili) genes, are significantly prevalent among strains of UPEC
that cause pyelonephritis4 and are characterized by their
mannose-resistant adherence to Gal(a1–4)Galb moieties
present in the globoseries of membrane glycolipids on
human erythrocytes of the P blood group and on
uroepithelial cells5,6 (for a good review on the discovery
and characterization of P fimbriae, see Johnson7 and Jones
et al.8). Structurally speaking, they are composed of B1000
copies of the major subunit protein, PapA, which polymerize
to form a rigid stalk that is connected to a flexible tip
consisting of limited copies of the minor subunit proteins,
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PapE and PapF, and receptor-binding adhesin, PapG, at the
distal end.9,10
THE THREE CLASSES OF PapG ADHESINS AND THEIR
PREVALENCE AMONG DIFFERENT UPEC ISOLATES
P fimbriae are chromosomally encoded by the pap gene
cluster, consisting of 11 genes, including papG, which
encodes the P-fimbrial adhesin. Upon characterization of
the PapG adhesin of UPEC isolate J96, Lund et al.11 identified
an additional structurally related fimbrial gene cluster, prs
(pap-related sequence). While Prs fimbriae were shown to be
serologically identical to P fimbriae (of the F13 serotype),
they displayed a different receptor-binding specificity.11 The
differences in receptor-binding specificity were attributed to
the adhesins, PapG and PrsG; in particular, trans-comple-
mentation of a P-fimbrial adhesin mutant (DpapG) with prsG
altered the binding specificity to that of Prs fimbriae.11
Two years later, Stro¨mberg et al.12 conducted a study
comparing the binding specificities of PapG and PrsG of
strain J96, and PapG from UPEC isolates IA2 and AD110 (of
the F72 and F11 P-fimbrial serotypes, respectively). Specifi-
cally, the four G adhesins were examined for binding
to purified glycolipids and mammalian erythrocytes and
uroepithelial cells. From those studies, they determined that
the four G adhesins represent three different isoreceptor-
binding variants (PapGI, -II, and -III). The isoreceptors
bound by the different PapG variants all contain a common
Gal(a1–4)Gal moiety linked to a ceramide group, which
anchors the receptor in the lipid bilayer.13 However, the
isoreceptors vary in the number of N-acetylgalactosamine
moieties added to the distal Gal(a1–4)Gal core, or by the
addition of sialic acid residues to form more complex
receptors.14,15 The type and distribution of the particular
isoreceptors among different host tissues and the different
binding preferences of the three PapG variants have been
shown to contribute to the differences in host tropism of
P-fimbriated E. coli.12
It was originally described that PapGI adhesins preferen-
tially bind globotriaosylceramide or GbO3 (abundant on
human uroepithelial cells), PapGII adhesins preferentially
bind globoside or GbO4 (abundant on human uroepithelial
cells), and PapGIII adhesins (or PrsG) preferentially
bind Forssman antigen or GbO5 (predominant on canine,
but not human uroepithelial cells).14 However, additional
studies have demonstrated that the PapG variants, in
particular PapGIII, bind to other isoreceptors present in
the urinary tract of humans.15–17 Recently, additional minor
PapG variants (of PapGI) as well as a new class of PapG
variants (PapGIV) have been reported.18,19 The isoreceptors
for which these new PapG variants bind is currently
unknown. Therefore, as we discover more isoreceptors and
more major or minor PapG variants, we can better under-
stand the host tropism and how it relates to a particular PapG
variant.
Clinically, the class II papG allele is primarily associated
with human pyelonephritis and bacteremia and the class III
papG allele is associated with human cystitis and with
genitourinary infections in dogs and cats.20–25 Interestingly,
the prevalence of the class II papG allele decreases in UPEC
strains isolated from adults with acute pyelonephritis and
urinary tract abnormalities and/or obstruction.26 Owing to
the rarity of the class I pap allele, not much is known about
its clinical association.
The class of PapG variant and the chromosomal location
of pap alleles typically differ among UPEC strains. The pap
gene clusters reside within pathogenicity islands that are
acquired by horizontal transfer and inserted within or
adjacent to specific tRNA genes. For example, in the
pyelonephritis isolates, CFT07327–29 and J96,30,31 two pap
gene clusters reside in separate pathogenicity islands near the
pheU and pheV tRNA genes. Interestingly, both papG genes
from CFT073 encode the PapGII adhesin variant, while the
two papG genes from J96 encode the PapGI and PapGIII
adhesin variants. UPEC cystitis isolate UTI8932,33 and UPEC
pyelonephritis isolate 53634,35 have a single pap gene cluster,
which is contained in one pathogenicity island that is
inserted near the leuX tRNA gene. Both papG genes from
UTI89 and 536 encode the PapGIII adhesin variant. UPEC
bacteremia isolate, CP9 (J96-like) has been shown to contain
two papG alleles that encode the PapGI and PapGIII
variants.36 Lastly, UPEC bacteriuria isolate IA2 and pyelone-
phritis isolates AD110 and DS17 all contain a single pap gene
cluster that encodes the PapGII variant.12,37–39
Figure 1 illustrates the conservation of amino-acid
sequences between the different PapG variants. Each of the
PapG adhesin sequences from UPEC strains J96, CP9, IA2,
CFT073, DS17, 536, and UTI89 were obtained from Entrez
PubMed and aligned using ClustalW software (MegAlign,
Lasergene 7). It is hypothesized that the differences in the
PapG amino-acid sequences allow for alterations in adhesin
binding and host specificity. Recently, both the solution
structure of the PapGII adhesin domain and the crystal
structure of the PapGII receptor bound to GbO4 (predomi-
nant isoreceptor of the human kidney) as well as the
unbound form of the adhesin have been determined using
multidimensional nuclear magnetic resonance and the
multiwavelength anomalous dispersion phasing method.40,41
In Figure 1, residues of PapGII that have been shown to be
involved in GbO4 receptor binding are boxed in red.40 Using
a series of sophisticated modeling programs, Dodson et al.40
were also able to predict the residues of PapGIII that make
contact with GbO5; in Figure 1, for comparison with the
PapGII-binding residues, the predicted contact residues of
PapGIII are boxed in green. This highlights the structural
conservation among PapG variants, while showing the
divergence leading to altered receptor specificities.
CONTRIBUTION OF P-FIMBRIAL-MEDIATED ADHERENCE TO
PYELONEPHRITIS AND THE PERSISTENCE OF UPEC IN THE
MAMMALIAN KIDNEY
Since the discovery of P fimbriae, it has been hypothesized
that these adhesins contribute to the pathogenesis of UPEC
20 Kidney International (2007) 72, 19–25
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within the mammalian urinary tract. An earlier study,
conducted in 1987, demonstrated that the serum of female
patients with symptoms of pyelonephritis contained P-
fimbrial antibodies, suggesting that P fimbriae were expressed
during infection.42 Similarly, another study conducted
shortly thereafter demonstrated that bacteria obtained from
midstream or catheterized urine specimens from patients
with E. coli cystitis expressed type 1 and P fimbriae.43 Thus,
both studies provided compelling evidence for the in vivo
expression of P fimbriae during human UTI.
To determine precisely the contribution of P fimbriae to
the pathogenesis of UPEC, additional studies have been
conducted using different animal models of infection. In
1985, O’Hanley et al.44 determined the distribution and
density of the P-fimbrial receptor within the urinary tract of
BALB/c mice to elucidate the molecular basis for renal
colonization. Using the mouse model of ascending infection,
they demonstrated that a Gal-Gal pili producing transfor-
mant of the nonpathogenic E. coli strain HB101 (obtained by
cloning random segments of a UPEC strain J96 cosmid
library into a moderate copy plasmid) was able to colonize
the kidneys of BALB/c mice in the absence of vesicoureteral
reflux unlike the nonpiliated HB101 parent strain.44 More-
over, subcutaneous and intramuscular vaccination of the
mice with purified Gal-Gal pili before infection could block
renal colonization upon infection with the Gal-Gal pili
producing UPEC strain J96.44 A similar study, conducted by
Hagberg et al.45 in 1983, also utilized UPEC strain J96 as a
donor to transform fecal-commensal E. coli strain 506 with
the pap gene cluster. In particular, they demonstrated that
transformants of 506 that contained the pap gene cluster
persisted within the kidneys of CBA and BALB/c mice more
efficiently than did the pap-negative transformants.45 It is
important to note that in both studies, wild-type UPEC levels
of pyelonephritis were never achieved with the commensal
E. coli pap transformants, suggesting that factors other than
P fimbriae are needed for optimal renal colonization.
Furthermore, while both studies demonstrate that addition
of P fimbriae to a commensal E. coli strain can allow for
better colonization, they do not prove that P fimbriae are
Figure 1 | Amino-acid sequence alignment of the three major PapG (or PrsG) adhesin variants from UPEC strains J96, CP9, CFT073, IA2,
DS17, 536, and UTI89. The amino-acid sequences, obtained from Entrez PubMed, are presented in single-letter code. The different PapG
variants are divided by a solid line. Residues that are homologous to the consensus (which is not shown) are shaded in yellow. Residues that are
not homologous to the consensus are shaded in blue. Residues of PapGII that have been shown to be involved in GbO4 receptor binding are
boxed in red.40 Residues of PapGIII that have been predicted to be in contact with GbO5 are boxed in green.40
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required for UPEC pathogenesis or that they contribute to
the fitness of UPEC during UTI.
To determine whether P fimbriae are indispensable for
UPEC pathogenesis, isogenic P-fimbrial mutants of different
UPEC strains have been constructed and studied in different
animal models of ascending UTI. The first study to
investigate the fitness of an isogenic P-fimbrial mutant
during ascending UTI was conducted by Hagberg et al.,45
along with the P-fimbrial transformant studies as described
previously. In particular, they demonstrated that a UPEC
strain lacking P fimbriae was significantly outcompeted by
wild-type UPEC in the kidneys of CBA and BALB/c mice
during mixed infection (or co-challenge).45 However, mu-
tants in that study were generated with the use of chemical
mutagenesis; since chemical mutagenesis often causes
secondary mutations, it would be impossible to know
whether the outcompetition of the P-fimbrial UPEC mutant
was solely due to loss of P fimbriae or some other UPEC
factor that was mutagenized. Several years later, our
laboratory utilized allelic exchange mutagenesis to create
precise deletions of papEFG (pheV copy) and papDEFG
(pheU copy), thus creating a double pap mutant of UPEC
strain CFT073 (UPEC76) that does not produce P fimbriae.46
Upon transurethral inoculation of CBA mice (N¼ 100) with
four different inoculum concentrations (105, 106, 107, and
109 CFU) of either CFT073 or UPEC76, it was demonstrated
that after 1 week of infection, no significant differences in
organism concentration or histological findings between the
wild-type and double-pap mutant were detected in the urine,
bladder, or kidney at any challenge concentration. Thus, it
was concluded that P fimbriae of UPEC are not required for
ascending UTI of CBA/J mice. A primate model of ascending
infection has also been used to study the contribution of P
fimbriae to UPEC pathogenesis, as monkeys are also known
to have the PapG adhesin receptors.47 In 1994, Roberts et al.39
demonstrated that an isogenic papG mutant of UPEC strain
DS17 (called DS17-8), created by allelic exchange mutagen-
esis, was equally able to cause bladder infection of
cynomolgous monkeys as compared to wild-type DS17, but
was unable to cause acute pyelonephritis such as wild-type
DS17 in this model as determined by histopathological
criteria and the concentration of the DS17-8 mutant within
the kidneys. Although the PapG adhesin mutant was shown
not to cause pyelonephritis, the establishment of P fimbriae
as a virulence factor, according to molecular Koch’s
postulates, has still not been fully satisfied because of the
lack of complementation of the mutant in vivo. In all, the
inconsistencies observed between each of the P-fimbrial
mutant animal studies could be explained by the differences
in animal models or UPEC strains utilized. Although both
mice and monkeys are known to have receptors for the PapG
adhesin, a study conducted in 1995 by Lanne et al.48 has
shown that the isoreceptor patterns present within the
kidneys of primates and mice differ significantly, thus
possibly contributing to differences in host specificity. Also,
different PapG variants expressed by the UPEC strains
studied (PapGI and -III of J96 and PapGII of CFT073 and
DS17) may also result in altered host specificity. Another
explanation could include differences in the host immune
response to P fimbriae, thus allowing some animal strains to
be less susceptible than others to P-fimbriated UPEC
infection. Lastly, because it is known that UPEC may have
the capacity to express up to 12 different fimbriae, it is
conceivable that loss of P-fimbrial-mediated adherence and
colonization may be compensated for by the expression of
another fimbrial type (discussed further in the next section).
More recent studies have uncovered a molecular crosstalk
between innate immune Toll-like receptor 4 binds bacterial
lipopolysaccharide signaling and P-fimbrial-mediated attach-
ment, which is lipopolysaccharide-independent (for a good
review see Bergsten49). Upon P-fimbrial attachment to its
glycosphingolipid receptor, ceramide is released from the
lipid part of the receptor; in particular, it has recently been
shown that ceramide acts as an agonist of Toll-like receptor 4
and potentially acts as a signaling intermediate between Toll-
like receptor 4 and the glycosphingolipid receptor.50 Activa-
tion of the Toll-like receptor 4 receptor by P-fimbrial
attachment subsequently leads to the production of proin-
flammatory cytokines and chemokines (interleukin-6 and
CXCL8, respectively) and recruitment of neutrophils.49
Although this proinflammatory response is beneficial in
initiating bacterial clearance, it also causes damage to the
surrounding tissue and is associated with renal complica-
tions. Since P fimbriae are implicated in triggering inflam-
mation, it can be deduced that they may also contribute to
the pathology and symptoms of acute pyelonephritis.
REDUNDANCY OF FIMBRIAL SYSTEMS IN UPEC
Upon sequencing of the different UPEC genomes, a number
of distinct fimbrial gene clusters have been identified. For
example, the sequencing of UPEC strain CFT073 has revealed
12 putative fimbrial gene clusters.29 The most extensively
studied fimbriae that have been shown to be important in
urinary tract colonization are the type 1, P, S, F1C, and
Dr/AFA adhesins. Each fimbrial type binds distinct isorecep-
tors found within the mammalian urinary tract: type 1
fimbriae bind N-linked oligomannose glycoproteins and
uroplakin,51 P fimbriae bind Gala(1–4)bGal moieties present
in the globoseries of glycolipids,5,6 S fimbriae bind a-sialyl-
2,3-b-galactoside-containing receptors,52,53 F1C fimbriae
bind lactosylceramide-containing receptors,54,55 and Dr/Afa
adhesins bind the Dr (aþ ) blood group antigen present on
the complement cascade regulator factor, decay-accelerating
factor.56 Although these fimbriae recognize different recep-
tors, each of the receptors may occupy sites within the same
tissue. For instance, type 1, P, S, F1C, and Dr fimbriae are all
known to bind to different sites within the human kidney
(Figure 2). Figure 2 illustrates the sites within the human
kidney where distinct fimbrial types have been shown
experimentally to bind.57 The fact that multiple fimbrial
types are able to bind to various sites of the human kidney
suggests that UPEC are provided with multiple means to
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establish renal adherence, thus, contributing to the patho-
gen’s overall success during renal colonization.
For the most part, E. coli express one fimbrial type at a
time.58 Thus, it is not surprising that ‘crosstalk’ occurs
between the regulators of the different fimbrial systems of
UPEC (for a good review see Holden59). Recently, our
laboratory and others have demonstrated that loss of one
fimbrial type leads to expression of another in UPEC.
Specifically, our laboratory showed that a mutant of UPEC
strain CFT073 unable to make type 1 and P fimbriae
produces F1C fimbriae, providing a compensatory mechan-
ism by which UPEC are still able to maintain adherence.60
This compensatory mechanism has also been observed for
UPEC strain UTI89, in which a mutant unable to make type
1 pili upregulated expression of S pili (Wright KJ, Seed PC,
Hultgren SJ, Abstr. 105th Gen. Meet. Am Soc Microbiol 2005;
abstract. B-176: 116). To provide an example, Figure 3
demonstrates that a type 1 fimbrial phase-locked derivative of
CFT073 that is unable to produce type 1 fimbriae (fim
L-OFF), expresses other fimbriae (panels C and D). The type
1 fimbrial phase-locked derivative of CFT073 that constitu-
tively expresses type 1 fimbriae (fim L-ON), which was
cultured statically as was the fim L-OFF derivative, is shown
for comparison (panels A and B). Together, these data
demonstrate that there exists a redundancy of fimbrial
systems in UPEC, which provides UPEC with multiple
alternatives to maintain adherence during UTI. Thus, as
previously discussed, the lack of importance for P fimbriae in
the CBA mouse model of infection46 could be explained by
the redundancy of fimbrial systems in UPEC strain CFT073
(which produces several fimbriae, including type 1, P, F1C,
and Dr fimbriae). In view of the data summarized in Figure 2,
it is possible that type 1, F1C, or Dr fimbriae may be
contributing to the colonization of the murine renal
epithelium in the absence of P-fimbrial expression.
SUMMARY, CONCLUSIONS, AND FUTURE PERSPECTIVES
P fimbriae, the best-studied fimbriae and first virulence-
associated factor described for UPEC, have been shown to be
Figure 2 | Cross-section of the human kidney displaying UPEC fimbrial adhesin-binding sites. Pyelonephritis is considered an ascending
infection, where UPEC from the bladder ascend through the ureters into the kidneys. Following ascension, UPEC are known to colonize the
collecting ducts, distal and proximal tubules, glomeruli, Bowman’s capsules, and the blood vessel walls (see inset). Specific UPEC fimbrial




Figure 3 | Transmission electron micrographs of UPEC expressing
different fimbriae. (a and b) CFT073 fim L-ON, a mutant that
constitutively expresses type 1 fimbriae. (c and d) CFT073 fim L-OFF, a
mutant that is unable to express type 1 fimbria produces another
type of fimbriae. a and c are at  34 000 magnification, and b and d
are at  64 000 magnification.
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associated with acute pyelonephritis. The pap gene cluster
encodes the proteins required for P-fimbrial synthesis,
including papG, the gene encoding the tip fimbrial adhesin.
Three major and well-studied classes of papG alleles exist,
which encode the molecular variants PapGI, -II, and -III.
Each PapG variant is known to have a distinct isoreceptor
specificity, which in turn results in altered host tissue
tropism. PapGII, which is clinically associated with acute
pyelonephritis in humans, has been shown to bind
preferentially globoside, or GbO4, the predominant glycoli-
pid isoreceptor of the human kidney. Various research using
different animal models of ascending UTI have found a
variable role for P fimbriae, and in particular PapGII-
mediated adherence, in the colonization of the mammalian
kidney. The disparities in the results obtained from those
studies are likely to be attributed to the differences in animal
models and UPEC strains utilized. One likely explanation
that was discussed in detail was the fact that UPEC produce
several different fimbrial types that are also known to bind to
different regions of the human kidney, and therefore, when P
fimbriae are unable to be expressed, other fimbriae could
compensate for their loss. Overall, it appears that there is a
subtle role for P fimbriae in mediating adherence to
uroepithelial cells in vivo and establishing a robust inflam-
matory response during renal colonization, which in turn
contributes to kidney damage during acute pyelonephritis. To
verify that P fimbriae contribute to the pathogenesis of UPEC
during ascending UTI (and in particular acute pyelone-
phritis), future studies should be conducted to satisfy fully all
three tenets of the molecular Koch’s postulates, including
complementation of a defined mutation. Furthermore, it may
be advantageous to investigate the spatial and temporal
expression of P fimbriae (and other fimbrial types) during in
vivo ascending infection to determine more precisely the role
and expression profile of P fimbriae (and other fimbriae)
during kidney colonization.
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